Distribution and antimicrobial resistance profile of common pathogens isolated from respiratory secretion in CHINET antimicrobial resistance surveillance program, 2005—2014

Chinese Journal of Infection and Chemotherapy

Volumn 16, Issue 5, 2016, Pages 541-550

  Yang, Qing ^a   Yu, Yunsong ^a   Lin, Jie ^a   Ni, Yuxing ^a   Sun, Jingyong ^a   Xu, Yingchun ^a   Zhang, Xiaojiang ^a   Sun, Ziyong ^a   Chen, Zhongju ^a   Wang, Fu ^a   Zhu, Demei ^a   Hu, Fupin ^a   Jiang, Xiaofei ^a   Wang, Chuanqing ^a   Wang, Aimin ^a   Zhuo, Chao ^a   Su, Danhong ^a   Hu, Yunjian ^a   Ai, Xiaoman ^a   Huang, Wenxiang ^a   Jia, Bei ^a   Zhang, Zhaoxia ^a   Ji, Ping ^a   Zhang, Hong ^a   Wang, Chun ^a   Wei, Lianhua ^a   Wu, Ling ^a   Xu, Yuanhong ^a   Shen, Jilu ^a   Shan, Bin ^a   Du, Yan ^a   Hu, Zhidong ^a   Li, Jin ^a   Xie, Yi ^a   Kang, Mei ^a   Han, Yanqiu ^a   Guo, Sufang ^a   Chu, Yunzhuo ^a   Tian, Sufei ^a   more..

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antimicrobial resistance surveillance; Pathogen; Respiratory tract infection

Indexed keywords

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BODILY SECRETIONS; CHINA; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY SECRETION; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

EID: 85018745526     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: 10.16718/j.1009-7708.2016.05.003     Document Type: Article

References (8)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth information supplement, 2014, M100-S24.
2. CDC.Antibotic resistance threats in the United States, 2013. [EB/OL]. [2015-04-03]. http://www.cdc.gov/drugresistance/threat-report-2013.
3. ZHAO C, SUN H, WANG H, LIU Y, et al. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program(2005-2010)[J]. Diagn Microbiol Infect Dis, 2012, 73(2): 174-181.
4. JINNO S, JACOBS MR. Pneumonia due to drug-resistant Streptococcus pneumonia[J]. Curr Infect Dis Rep, 2012, 14(3): 292-299.
5. TOMIC V, DOWZICKY MJ. Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial(T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T.(2004-2008)[J]. Ann Clin Microbiol Antimicrob, 2014, 13: 52.
6. SHEN P, WEI Z, JIANG Y, et al. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China[J]. Antimicrob Agents Chemother, 2009, 53(10): 4333-4338.
7. WANG X, XU X, LI Z, et al. An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China[J]. Microb Drug Resist, 2014, 20(2): 144-149.
8. DAIKOS GL, TSAOUSI S, Tzouvelekisls A, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections : lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58(4): 2322-2328.